Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets EXMKT - Delayed Quote USD

Transgene SA (TRGNF)

Compare
0.7000
0.0000
(0.00%)
At close: April 15 at 4:00:00 PM EDT
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
307
307
1,450
3,126
9,993
Operating Expense
28,239.8000
28,239.8000
23,145
32,862
33,739
Operating Income
-27,932.8000
-27,932.8000
-21,695
-29,736
-23,746
Net Non Operating Interest Income Expense
1,687
1,687
7,719
-3,323
3,734
Pretax Income
-33,971
-33,971
-22,328
-32,804
-19,536
Net Income Common Stockholders
-33,971
-33,971
-22,328
-32,804
-19,536
Diluted NI Available to Com Stockholders
-33,971
-33,971
-22,328
-32,804
-19,536
Basic EPS
-0.29
--
-0.22
-0.33
-0.21
Diluted EPS
-0.29
--
-0.22
-0.33
-0.21
Basic Average Shares
117,141.3790
--
101,490.9090
99,501.9600
91,111.6490
Diluted Average Shares
117,141.3790
--
101,490.9090
99,501.9600
91,111.6490
Total Operating Income as Reported
-35,658
-35,658
-30,047
-29,904
-23,525
Total Expenses
28,239.8000
28,239.8000
23,145
32,862
33,739
Net Income from Continuing & Discontinued Operation
-33,971
-33,971
-22,328
-32,804
-19,536
Normalized Income
-33,971
-33,971
-22,328
-32,798
-19,532
Interest Income
--
--
--
--
4,198
Interest Expense
--
--
168
804
464
Net Interest Income
1,687
1,687
7,719
-3,323
3,734
EBIT
-27,932.8000
-27,932.8000
-21,695
-32,000
-19,072
EBITDA
-26,651.8000
-26,651.8000
-20,123
-30,314
-16,551
Reconciled Depreciation
1,281
1,281
1,572
1,686
2,521
Net Income from Continuing Operation Net Minority Interest
-33,971
-33,971
-22,328
-32,804
-19,536
Total Unusual Items Excluding Goodwill
--
--
-35
-6
-4
Total Unusual Items
--
--
-35
-6
-4
Normalized EBITDA
-26,651.8000
-26,651.8000
-20,123
-30,308
-16,547
12/31/2021 - 1/8/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AOBI American Oriental Bioengineering, Inc.
0.0005
0.00%
 
KDEV.ST Karolinska Development AB (publ)
0.8720
-1.36%
 
LVTX LAVA Therapeutics N.V.
1.1400
-1.72%
 
EPIX ESSA Pharma Inc.
1.6300
-1.21%
 
LYEL Lyell Immunopharma, Inc.
0.4588
+3.19%
 
VALN Valneva SE
7.05
+0.43%
 
MGNX MacroGenics, Inc.
1.2600
-0.79%
 
AVIR Atea Pharmaceuticals, Inc.
2.8200
-4.08%
 
FDMT 4D Molecular Therapeutics, Inc.
3.1000
+11.51%
 
CHRS Coherus BioSciences, Inc.
1.0600
+8.76%